Towers Watson
TW
$104.20
+2.72%
Tradeweb Markets Inc. operates leading electronic trading platforms for fixed income, derivatives, and money markets, connecting institutional investors, broker-dealers, and retail clients across US and European government debt, mortgage-backed securities, interest-rate swaps, and corporate bonds, while also selling market data and pricing services. The company is a scaled, network-effect platform business that has been a primary beneficiary of the secular electronification of fixed-income markets, competing against legacy voice brokers and other electronic venues. The current investor narrative centers on whether Tradeweb can sustain its roughly 20% revenue growth trajectory as rate volatility normalizes, with recent quarterly results showing accelerating top-line momentum and expanding profitability even as the stock has de-rated sharply over the past year. Debate is split between bulls who see a durable, high-margin compounder trading at a rare discount and skeptics concerned that cyclical trading volumes and a compressed multiple reflect structural growth deceleration.…
TW
Towers Watson
$104.20
Investment Opinion: Should I buy TW Today?
The synthesized recommendation is Buy, with a one-sentence thesis: Tradeweb is a high-quality, cash-generative platform business trading at a rare valuation discount (22.1x forward PE, 0.459 PEG) with accelerating revenue growth (21.2% YoY) and a pristine balance sheet, offering 21.9% upside to the analyst average target of $123.64. The consensus 'buy' rating (mean 2.2 from 14 analysts) and recent Goldman Sachs upgrade to Buy reinforce the positive view.
Supporting evidence includes: (1) revenue growth accelerating to 21.2% YoY in Q1 2026 from roughly flat quarterly growth in 2025; (2) exceptional profitability with a 33.2% net margin, 67.98% gross margin, and 46.5% operating margin; (3) a fortress balance sheet with $1.94 billion in cash, 0.043 debt-to-equity, and a 4.94 current ratio; (4) trailing-twelve-month free cash flow of $1.13 billion with a low 12.6% dividend payout ratio; and (5) a forward PE of 22.1x and PEG of 0.459, which screen as attractive relative to the company's growth rate and historical multiples of 40-60x. The implied upside to the analyst average target is 21.9%, and the stock trades at a discount to its own history on both PE and PS bases.
The biggest risks that could invalidate the thesis are: (1) a sharp deceleration in transaction-fee revenue if rate volatility normalizes, which would undermine the growth narrative; (2) multiple compression if the market continues to de-rate high-growth financial platforms; and (3) competitive pressure from legacy brokers or new electronic venues eroding market share. The rating would upgrade to a stronger Buy if forward PE compresses below 20x while revenue growth remains above 20%, or downgrade to Hold if revenue growth decelerates below 15% or if operating margins fall below 40%. Relative to its history and peers, the stock appears undervalued, trading at 22.1x forward earnings versus a historical range of 17.7x to over 100x, and at an 11.17x PS ratio versus 40-62x in 2024-2025.
Sign up to view all
TW 12-Month Price Forecast
Tradeweb presents a compelling risk/reward for patient investors: the company is growing revenue at 21.2% with 46.5% operating margins and a pristine balance sheet, yet trades at 22.1x forward earnings, near the low end of its historical valuation range. The stock's 15.2% one-year decline and -31.4 percentage point relative strength deficit suggest the market has already priced in a significant slowdown, creating an asymmetric opportunity if growth persists. However, the wide analyst target range and the cyclical nature of transaction-fee revenue introduce meaningful uncertainty, warranting a medium confidence stance. I would upgrade to high confidence if Q2 2026 results confirm sustained 20%+ revenue growth with stable margins, and downgrade to neutral if revenue growth decelerates below 15% or if operating margins slip below 42%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Towers Watson's 12-month outlook, with a consensus price target around $123.64 and implied upside of +18.7% versus the current price.
Average Target
$123.64
0 analysts
Implied Upside
+18.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$98 - $178
Analyst target range
Coverage is solid with 14 analysts, and the consensus recommendation is "buy" with a recommendation mean of 2.2 on a scale where lower is more bullish. The average target price of $123.64 implies roughly 21.9% upside from the current price of $101.44, a spread that suggests the sell-side views the recent weakness as overdone. Consensus estimates call for EPS of $6.90 (range $6.65-$7.23) and revenue of $3.48 billion (range $3.38-$3.61 billion), and the bullish tilt is reinforced by recent actions including Goldman Sachs upgrading to Buy from Neutral on June 30, 2026, alongside reiterated Buy/Overweight ratings from UBS and JP Morgan.
The target range is unusually wide, from a low of $98.00 to a high of $178.00 — a 81.6% spread that signals significant disagreement about the company's trajectory. The low target of $98.00, just 3.4% below the current price, prices in flat-to-modest growth and multiple compression, effectively a bear case of normalized trading volumes and competitive pressure. The high target of $178.00, 75.5% above the current price, assumes a re-rating toward historical multiples on sustained 20%+ growth and operating leverage. The clustering of recent ratings around Equal Weight/Hold (Morgan Stanley, Barclays, TD Cowen) versus Buy/Outperform (Goldman, UBS, JP Morgan, Raymond James) indicates a market still debating whether the de-rating is a buying opportunity or a warning, and the wide dispersion argues for position sizing that respects the elevated uncertainty.
Drowning in data?
Find the real signal!
Bulls vs Bears: TW Investment Factors
The bull case rests on accelerating revenue growth (21.2% YoY), exceptional profitability (33.2% net margin, 46.5% operating margin), a fortress balance sheet ($1.94B cash, 0.043 debt-to-equity), and a valuation near historical lows (22.1x forward PE, 0.459 PEG). The bear case centers on severe relative underperformance (-31.41 percentage points over one year), a stock trading in the lower third of its 52-week range, revenue concentration in cyclical transaction fees, and wide analyst dispersion (target range $98-$178). On balance, the bull evidence appears stronger: the fundamental acceleration in Q1 2026 is tangible, the balance sheet is pristine, and the valuation has compressed to levels that historically preceded strong returns. The single most important tension is whether the Q1 2026 revenue inflection represents a durable new growth trajectory or a cyclical peak driven by elevated rate volatility; if it is the former, the stock is deeply undervalued, but if it is the latter, the de-rating may continue.
Bullish
- Revenue growth accelerating to 21.2%: Q1 2026 revenue of $617.8 million rose 21.21% year over year, a sharp acceleration from the roughly flat $510-520 million quarterly run-rate through 2025. The sequential step-up of nearly $100 million from Q4 2025 signals a genuine inflection in trading activity and platform adoption rather than seasonal noise.
- Exceptional profitability with expanding margins: Q1 2026 net income of $205.3 million produced a 33.2% net margin, while gross margin reached 67.98% and operating margin hit 46.5%. Gross margin has trended from 65.3% in Q1 2025 to 68.0% in Q1 2026, demonstrating operating leverage as revenue scales.
- Fortress balance sheet with $1.94B cash: Debt-to-equity is just 0.043 and the current ratio is 4.94, with $1.94 billion in cash against negligible debt. Trailing-twelve-month free cash flow of $1.13 billion provides enormous flexibility for buybacks, dividends, or strategic investment.
- Valuation near historical lows: The trailing PE of 28.2x and forward PE of 22.1x sit in the lower portion of Tradeweb's multi-year range, well below the 40-60x seen through 2023-2024. The PS ratio of 11.17x is dramatically below the 40-62x readings from 2024-2025, suggesting the de-rating may be overdone.
Bearish
- Severe relative underperformance persists: The stock is down 15.19% over one year versus the S&P 500's +16.22%, a relative strength deficit of -31.41 percentage points. Over six months, the underperformance is even starker at -33.87 percentage points, indicating sustained institutional distribution.
- Trading in lower third of 52-week range: At $101.44, the stock sits at roughly 27.6% of its 52-week range of $91.42 to $127.69, closer to the low than the high. The failure to reclaim even the midpoint underscores the absence of buyers willing to chase the name despite strong fundamentals.
- Transaction-fee concentration creates cyclicality: Transaction fees of $523.8 million dominate the revenue mix, meaning growth is heavily levered to trading volumes and rate volatility. As rate volatility normalizes, this concentration could cause revenue growth to decelerate sharply from the 21.2% Q1 2026 pace.
- Wide analyst target dispersion signals uncertainty: The target range spans from $98.00 to $178.00, an 81.6% spread that reflects deep disagreement about the company's trajectory. The low target of $98.00 is just 3.4% below the current price, effectively pricing in flat-to-modest growth and multiple compression.
TW Technical Analysis
Tradeweb is in a sustained downtrend, with the shares down 15.19% over the past year and 18.47% over six months, badly lagging the S&P 500's +16.22% one-year return. At $101.44, the stock sits at roughly 27.6% of its 52-week range of $91.42 to $127.69, meaning it is trading in the lower third of its annual band and closer to its lows than its highs — a positioning that signals persistent distribution rather than momentum, though it also means much of the bad news may already be discounted. The 52-week high of $127.69 was set earlier in the period, and the failure to reclaim even the midpoint of the range underscores the absence of buyers willing to chase the name.
Short-term momentum is weak but stabilizing: the stock is down 2.39% over the past month versus the S&P 500's -1.06%, a relative underperformance of 1.33 percentage points, while the three-month change is a marginal +0.25% against the index's +3.04%. This divergence — flat-to-slightly-positive over three months but negative over one month and deeply negative over twelve — suggests the downtrend is decelerating rather than accelerating, consistent with a basing pattern. The stock's beta of 0.626 indicates it moves only about 63% as much as the market, so the magnitude of its underperformance is notable given its typically defensive trading profile; the 2.94 short ratio and modest daily volume of roughly 1.04 million shares suggest no aggressive short-side conviction, but also no urgent institutional accumulation.
Key technical levels are well defined: support sits at the 52-week low of $91.42, roughly 9.9% below the current price, while resistance is the 52-week high of $127.69, about 25.9% above. A breakdown below $91.42 would confirm the multi-quarter downtrend and likely trigger momentum-driven selling, whereas a breakout above $127.69 would require a fundamental catalyst to reverse the relative-strength deficit of -31.41 percentage points over one year. The maximum drawdown of -33.84% over the period illustrates the severity of the de-rating, and with beta at 0.626, position sizing should account for a stock that historically offers below-market volatility but has recently delivered meaningfully negative alpha.
Beta
0.63
0.63x market volatility
Max Drawdown
-32.1%
Largest decline past year
52-Week Range
$91-$128
Price range past year
Annual Return
-11.6%
Cumulative gain past year
| Period | TW Return | S&P 500 |
|---|---|---|
| 1m | -2.0% | -2.0% |
| 3m | +2.1% | +1.4% |
| 6m | -15.6% | +15.0% |
| 1y | -11.6% | +15.7% |
| ytd | -1.9% | +11.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TW Fundamental Analysis
Revenue is growing robustly and, importantly, accelerating: Q1 2026 revenue of $617.8 million rose 21.21% year over year, up from $509.7 million in Q1 2025, $513.0 million in Q2 2025, $508.6 million in Q3 2025, and $521.2 million in Q4 2025. The sequential step-up from roughly $510-520 million per quarter through 2025 to $617.8 million in Q1 2026 represents a meaningful inflection, and the revenue mix is dominated by transaction fees at $523.8 million, supplemented by subscription fees of $60.3 million, market data revenue of $26.7 million, and other financial services revenue of $6.9 million. The transaction-fee concentration means growth is levered to trading volumes and volatility, but the recurring subscription and data streams provide a stabilizing base that supports the premium multiple.
Profitability is exceptional for a capital-markets platform: Q1 2026 net income was $205.3 million on $617.8 million of revenue, a 33.2% net margin, while gross margin was 67.98% and operating margin reached 46.5%. Gross margin has been stable-to-improving across recent quarters — 65.3% in Q1 2025, 66.9% in Q2 2025, 67.6% in Q3 2025, 69.4% in Q4 2025, and 68.0% in Q1 2026 — and net income has grown from $148.4 million in Q1 2025 to $205.3 million in Q1 2026, a 38.4% increase. The Q4 2025 net margin of 62.4% was inflated by a $225.9 million other-income gain, so the underlying operating margin in the mid-40s is the more reliable profitability gauge, and it remains well above typical financial-exchange peers.
The balance sheet is fortress-like: debt-to-equity is just 0.043, the current ratio is 4.94, and cash at the end of Q1 2026 stood at $1.94 billion against negligible debt. Free cash flow on a trailing-twelve-month basis is $1.13 billion, with Q4 2025 free cash flow of $321.1 million and Q3 2025 of $310.9 million, though Q1 2026 free cash flow dipped to $94.2 million due to a $234.0 million working-capital outflow. ROE of 12.49% and ROA of 12.48% are solid but understated by the company's large cash pile, and with a dividend payout ratio of just 12.6% and a dividend yield of 0.45%, Tradeweb generates far more cash than it returns, leaving ample internal funding capacity for growth investments and buybacks.
Quarterly Revenue
$617764000.0B
2026-03
Revenue YoY Growth
+21.2%
YoY Comparison
Gross Margin
68.0%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TW Overvalued?
Because Tradeweb is solidly profitable — Q1 2026 net income of $205.3 million and trailing EPS of $0.035 on a reported basis, though the more representative forward EPS estimate is $6.90 — the PE ratio is the appropriate primary metric. The trailing PE of 28.23x compares to a forward PE of 22.09x, a roughly 22% compression that implies the market expects meaningful earnings growth over the next twelve months, consistent with the consensus revenue estimate of $3.48 billion and EPS estimate of $6.90. The PEG ratio of 0.459 is strikingly low, suggesting the stock is cheap relative to its expected growth rate if those estimates are met.
Relative to the broader financial-capital-markets sector, Tradeweb's 28.2x trailing PE and 22.1x forward PE screen as a premium to traditional asset managers and banks but a discount to high-growth exchange and data peers; the PS ratio of 11.17x and EV/EBITDA of 14.80x are moderate for a business with 67.3% gross margins and 41.2% operating margins. The 3.52x price-to-book and 19.64x price-to-cash-flow ratios reflect the asset-light, high-return nature of the platform model, and the 0.45% dividend yield is incidental rather than a valuation support. The premium to the market is justified by the 21.2% revenue growth and mid-40s operating margins, but the stock's 15.2% one-year decline suggests the market has already compressed the multiple to reflect slower expected volume growth.
Historically, Tradeweb's PE has ranged from roughly 17.7x (Q4 2025) to over 100x in earlier periods, with the trailing PE of 28.2x sitting in the lower portion of its multi-year band and well below the 40-60x range seen through much of 2023-2024. The PS ratio of 11.17x is dramatically below the 40-62x readings from 2024-2025, reflecting both the stock's price decline and the sharp increase in revenue. This places the current valuation near the bottom of its own historical range, which could signal a genuine value opportunity if growth persists, or reflect the market pricing in a structural slowdown in trading activity.
PE
28.2x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 31x~58x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are relatively contained given Tradeweb's fortress balance sheet, but the revenue mix presents a structural vulnerability. Transaction fees of $523.8 million accounted for roughly 85% of Q1 2026 revenue, tying the company's growth directly to trading volumes and market volatility. While subscription fees ($60.3 million) and market data revenue ($26.7 million) provide a stabilizing recurring base, they are too small to offset a sharp decline in transaction activity. Additionally, Q1 2026 free cash flow of $94.2 million was depressed by a $234.0 million working-capital outflow, highlighting that cash generation can be volatile even for a highly profitable business. The 33.2% net margin and 46.5% operating margin are exceptional, but they also mean there is little room for cost-cutting to protect earnings if revenue growth stalls.
Market and competitive risks are significant given the stock's persistent underperformance and premium valuation relative to traditional financial peers. The trailing PE of 28.2x and PS ratio of 11.17x represent a premium to banks and asset managers, leaving the stock vulnerable to multiple compression if growth decelerates. The beta of 0.626 indicates below-market volatility, but the stock has recently delivered meaningfully negative alpha, with a -31.41 percentage point relative strength deficit over one year. Competitive threats from legacy voice brokers and other electronic venues could pressure market share, while regulatory changes in fixed-income markets could alter the competitive landscape. The wide analyst target range of $98 to $178 signals that even the sell-side cannot agree on the growth trajectory, creating potential for sharp repricing if sentiment shifts.
In a worst-case scenario, a normalization of rate volatility would cause transaction-fee revenue to decline, exposing the cyclicality of the business model and triggering a re-rating toward the low end of historical multiples. If revenue growth decelerates to single digits and the forward PE compresses to 17-18x (the low end of its historical range), the stock could fall to the 52-week low of $91.42, representing a 9.9% decline from the current price of $101.44. A more severe scenario, where the market prices in structural stagnation and the stock tests the analyst low target of $98.00, would imply a 3.4% decline, but if the multiple compresses further to 15x forward earnings on lower EPS estimates, the downside could extend to $80-$85, a 16-21% decline. The maximum drawdown of -33.84% over the past year illustrates that such moves are not unprecedented.
FAQ
The most severe risk is revenue concentration in transaction fees ($523.8 million of $617.8 million in Q1 2026), which ties growth to trading volumes and rate volatility; a normalization could cause revenue growth to decelerate sharply. Second, competitive pressure from legacy voice brokers and other electronic venues could erode market share, particularly in interest-rate swaps and corporate bonds. Third, valuation compression risk remains: despite the de-rating, the stock still trades at a premium to traditional financial peers, and further multiple contraction could occur if growth slows. Fourth, cash flow volatility is a concern, as Q1 2026 free cash flow dipped to $94.2 million due to a $234.0 million working-capital outflow, though trailing-twelve-month free cash flow remains robust at $1.13 billion.
The 12-month forecast is divided into three scenarios: a base case (50% probability) with a target range of $115-$130, aligned with the analyst average target of $123.64; a bull case (30% probability) targeting $140-$178, driven by sustained 20%+ growth and multiple re-rating; and a bear case (20% probability) targeting $85-$98, assuming revenue deceleration and further multiple compression. The base case is most likely, predicated on revenue growth decelerating to 15-18% but remaining well above sector averages, with operating margins holding in the mid-40s. The key assumption is that rate volatility remains sufficient to support trading volumes without disrupting markets, and that no major competitive or regulatory shocks occur.
TW appears undervalued relative to its own history and growth rate. The trailing PE of 28.2x and forward PE of 22.1x are well below the 40-60x range seen through 2023-2024, and the PS ratio of 11.17x is dramatically lower than the 40-62x readings from 2024-2025. The PEG ratio of 0.459 suggests the stock is cheap relative to expected earnings growth, and the EV/EBITDA of 14.8x is moderate for a business with 67.3% gross margins. However, the stock trades at a premium to traditional banks and asset managers, so the valuation is only attractive if the company sustains its 20%+ growth trajectory. The market appears to be pricing in a slowdown in trading activity, which creates opportunity if that expectation proves too pessimistic.
From a risk/reward perspective, TW offers a favorable setup: the stock trades at $101.44 with a consensus analyst target of $123.64, implying 21.9% upside, and the forward PE of 22.1x is near the low end of its historical range. The company is growing revenue at 21.2% YoY with a 33.2% net margin and holds $1.94 billion in cash against negligible debt. The biggest downside risk is a normalization of rate volatility that could slow transaction-fee revenue and compress the multiple, potentially sending the stock to the 52-week low of $91.42 (a 9.9% decline). For long-term investors comfortable with cyclical exposure to trading volumes, TW is a good buy at current levels, but position sizing should account for the wide analyst target range ($98-$178) and the stock's recent relative underperformance.
TW is best suited for long-term investment, with a suggested minimum holding period of 2-3 years. The company is in a growth stage, benefiting from the secular electronification of fixed-income markets, and its beta of 0.626 indicates below-market volatility, making it less suitable for short-term trading. The dividend yield of 0.45% is incidental and not a source of income, so returns depend on capital appreciation driven by revenue growth and multiple expansion. Earnings visibility is moderate, with 14 analysts covering the stock and a consensus 'buy' rating, but the wide target range ($98-$178) reflects uncertainty about the growth trajectory. Short-term traders may find opportunities around earnings releases, but the stock's recent relative underperformance and lack of momentum make it a poor candidate for tactical trading.
